To assess the associations of semaglutide with recurrent CUD, the study population included 2034 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications during 6/202112/2022 (time zero or index event), had a diagnosis of CUD on or before the index event, and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event
(5) Immunometabolic Reprogramming: Polarization of ATMs toward M2 phenotypes with concurrent suppression of NF-B/STAT3 inflammatory cascades
She has counselled and educated clients in Hong Kong, whose health goals ranged from weight loss to detox and hormone balancing
Biosci Biotechnol Biochem 58:18421844 Yokoyama A, Adachi K, Shizuri Y (1995) New carotenoid glucosides, astaxanthin glucoside and adonixanthin glucoside, isolated from the astaxanthin-producing marine bacterium, Agrobacterium aurantiacum
Research shows that women with lupus experience the negative effects of obesity at a lower BMI than the general population